Granules India Limited, incorporated in 1991, is a vertically integrated and fast growing Indian pharmaceutical company headquartered in Hyderabad. With best-in-class facilities and a strong commitment to operational excellence, quality, and customer service, Granules is one of the few pharmaceutical companies globally involved across the entire manufacturing value chain—from Active Pharmaceutical Ingredients (APIs) and Pharmaceutical Formulation Intermediates (PFIs) to Finished Dosages (FDs).

Granules serves over 300 customers across regulated and semi-regulated markets, with a global footprint spanning more than 80 countries. The company operates 10 manufacturing facilities—eight in India, two in the USA—and recently expanded its global footprint with the addition of a Contract Development and Manufacturing Organization (CDMO) facility in Europe. 

Granules facilities are approved by leading regulatory agencies including the US FDA, EDQM, EU GMP, COFEPRIS, WHO GMP, TGA, KFDA, DEA, MCC, and HALAL.